Last week, at its third “Access to Markets” event, the Investing in Innovation Africa (i3) programme announced three agreements involving African health startups, focused on cervical cancer prevention, malaria control and access to medicines through pharmacies. The deals form part of a broader strategy to scale and finance health technology innovation across Africa.